Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI
Maastricht University Medical Center
Maastricht University Medical Center
Palleon Pharmaceuticals, Inc.
Sensei Biotherapeutics, Inc.
Columbia University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins